About Drupal 8
Have you ever felt that your website needs to be more personalized, integrated with cutting-edge technology to offer enhanced user experience?
Valuebound is one of those companies, which specifically help organizations in their path to digital transformation. We enhance digital experience for end users with tailored web applications.
Recent releases
|
Customer experience Journey: Mapping, Stages and Examples
The customer experience journey is the business pathway that effectively shapes how customers perceive and engage with your brand. There's a need to understand that because it provides insights…
|
Unlocking the Power of AI in Customer Experience
In the present times when customer interaction has become the cornerstone of brand strategy, the relationship between AI and customer experience is also evolving. Businesses are now presented with…
|
Customer Experience Automation (CXA): What is it?
In the modern business landscape, customer experience automation (CXA) is becoming a game changer. Businesses are no longer relying solely on traditional customer service channels. Instead, they are…
|
Top 5 Digital Experience Trends for Business Leaders
Understanding the latest digital experience trends has never been more important for businesses looking to thrive in an evolving market. At ValueBound, we focus on not just building solutions but…
CASE STUDY
See all our work
How a Top Indian Pharma Brand Boosted HCP Engagement Using Tech-Led Omnichannel Marketing
India’s renowned pharmaceutical company, known for its strong presence in chronic therapy areas, was facing a growing disconnect with its most important audience: healthcare professionals.
How a Leading Indian Pharma Brand Expanded Reach Across Semi-Urban & Rural Regions
A leading pharmaceutical company in India, well known for its OTC presence and deep connection with mass-market audiences, was preparing to launch a public awareness campaign focused on maternal he
Driving Digital Engagement for a Chronic Care Program with Tech-Led Pharma Marketing
A leading pharmaceutical company in India, known for its chronic care drug portfolio, was preparing to launch a support program aimed at patients diagnosed with congestive heart failure (CHF).
